Sally Beauty Holdings (SBH) 27.68 $SBH Sally Beauty

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2016 at 5:07 PM

Sally Beauty Holdings (SBH) 27.68 $SBH

Sally Beauty (SBH): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 10:20AM CDT
Sally Beauty Holdings Inc. (SBH) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
SBH: 27.68 (-0.03)

Sally Beauty Holdings Set to Possibly Rebound After Yesterday's Selloff of 1.94%
Comtex SmarTrend(R) - Fri Aug 26, 2:34PM CDT
Sally Beauty Holdings (NYSE:SBH) traded in a range yesterday that spanned from a low of $27.25 to a high of $27.89. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $27.70 on volume of 703,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SBH: 27.68 (-0.03)

Short Interest In Sally Beauty Holdings Moves 12% Higher
MarketNewsVideo.com - Wed Aug 10, 1:57PM CDT
The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 818,735 share increase in total short interest for Sally Beauty Holdings Inc , to 7,686,177, an increase of 11.92% since 07/15/2016. Total short...
SBH: 27.68 (-0.03)

Specialty Retailer Stocks Technical Reports -- Pier 1 Imports, Sally Beauty, Finish Line, and KAR Auction Services
PR Newswire - Wed Aug 10, 6:50AM CDT
Today, Stock-Callers.com directs investors' attention to the Specialty Retail segment which contributes about 30% of consumer spending in the US. Retail sales growth is dependent on several factors such as higher wages, more jobs, and improved consumer sentiment. Stocks in focus are: Pier 1 Imports Inc. (NYSE: PIR), Sally Beauty Holdings Inc. (NYSE: SBH), Finish Line Inc. (NASDAQ: FINL), and KAR Auction Services Inc. (NYSE: KAR). Download the free research reports on these stocks today:
PIR: 4.65 (+0.09), KAR: 42.61 (-0.14), SBH: 27.68 (-0.03), FINL: 23.75 (-0.52)

Health & Beauty Industry Forecasted to Generate Over $60 Billion in Revenue by Year's End in U.S. Alone; Company Issues 10Q with Increased Revenue Results
PR Newswire - Tue Aug 09, 7:30AM CDT
The beauty industry's potential to continue to remain profitable as consumers spend millions for health and beauty products, salon experiences and other industry related services and products. The revenue of the U.S. cosmetic industry alone is estimated to amount to about 62.46 billion U.S. dollars in 2016.
AVP: 5.92 (+0.09), COTY: 25.88 (-0.55), SBH: 27.68 (-0.03), EL: 89.47 (-0.15)

Sally Beauty (SBH) Down 10% on Q3 Revenue Miss, Earnings Match Estimates
Madeleine Johnson - Zacks Investment Research - Thu Aug 04, 12:24PM CDT
On Thursday, beauty supply company Sally Beauty Co. (SBH) reported its fiscal 2016 third quarter results, sending its stock sliding around 10% in midday trading.
SBH: 27.68 (-0.03)

Sally Beauty Holdings, Inc. Announces the Appointment of Erin Nealy Cox to the Board of Directors
BusinessWire - Thu Aug 04, 5:30AM CDT
The Board of Directors of Sally Beauty Holdings today announced the appointment of Erin Nealy Cox as an independent director effective August 1, 2016. Ms. Nealy Cox will be a member of the Audit Committee of the Board of Directors.
SBH: 27.68 (-0.03)

Sally Beauty Holdings, Inc. Announces Fiscal 2016 Third Quarter Results
BusinessWire - Thu Aug 04, 5:30AM CDT
--Consolidated gross margin 50.0%, up 30 bps over prior year
SBH: 27.68 (-0.03)

Look for Shares of Sally Beauty Holdings to Potentially Pullback after Yesterday's 2.47% Rise
Comtex SmarTrend(R) - Wed Aug 03, 3:22PM CDT
Sally Beauty Holdings (NYSE:SBH) traded in a range yesterday that spanned from a low of $28.25 to a high of $29.66. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $29.51 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SBH: 27.68 (-0.03)

How These Services' Stocks are Performing? - Tiffany, Pier 1 Imports, Signet Jewelers, and Sally Beauty
PR Newswire - Wed Jun 22, 6:30AM CDT
Growth is expected for the Services sector over the next couple of years, and several companies are signaling long-term potential. This morning, Stock-Callers.com takes a look at four equities in this space for review: Tiffany & Co. (NYSE: TIF), Pier 1 Imports Inc. (NYSE: PIR), Signet Jewelers Ltd (NYSE: SIG), and Sally Beauty Holdings Inc. (NYSE: SBH). Learn more about these stocks and receive your complimentary trade alerts at:
PIR: 4.65 (+0.09), SBH: 27.68 (-0.03), TIF: 69.17 (-0.91), SIG: 81.10 (-0.90)

SmarTrend Watching for Potential Rebound in Shares of Sally Beauty Holdings After 1.08% Loss
Comtex SmarTrend(R) - Wed Jun 08, 2:21PM CDT
Sally Beauty Holdings (NYSE:SBH) traded in a range yesterday that spanned from a low of $29.88 to a high of $30.68. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $29.93 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SBH: 27.68 (-0.03)

Upgrade Alert for Sally Beauty Holdings (SBH)
Comtex SmarTrend(R) - Fri Jun 03, 3:40AM CDT
Sally Beauty Holdings (NYSE:SBH) was upgraded from Underperform to Market Perform at Wells Fargo today. The stock closed yesterday at $30.38 on volume of 2.9 million shares, above average daily volume of 1.3 million. Sally Beauty Holdings, Inc. distributes and retails beauty products. The Company distributes products directly to salons, and retails beauty products through a chain of cash and carry stores.
SBH: 27.68 (-0.03)

Sally Beauty Holdings Set to Possibly Pullback After Yesterday's Rally of 1.03%
Comtex SmarTrend(R) - Fri May 27, 2:23PM CDT
Sally Beauty Holdings (NYSE:SBH) traded in a range yesterday that spanned from a low of $28.05 to a high of $28.75. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $28.37 on volume of 573,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SBH: 27.68 (-0.03)

Sally Beauty Holdings Falls 4.04% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu May 05, 1:24PM CDT
Sally Beauty Holdings (NYSE:SBH) traded in a range yesterday that spanned from a low of $30.38 to a high of $32.11. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $31.10 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SBH: 27.68 (-0.03)

Avon (AVP) Slips to Loss in Q1, Alters Reporting Segments
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:41AM CDT
Avon Products Inc. (AVP) reported adjusted loss per share continuing operations of 7 cents for first-quarter 2016, reflecting a marked deterioration from earnings of 3 cents per share in the year-ago quarter.
AVP: 5.92 (+0.09), NUS: 59.39 (+0.47), SBH: 27.68 (-0.03), EL: 89.47 (-0.15)

Sally Beauty beats Street 2Q forecasts
Automated Insights - Thu May 05, 5:37AM CDT
DENTON, Texas (AP) _ Sally Beauty Holdings Inc. (SBH) on Thursday reported fiscal second-quarter profit of $60.2 million.
SBH: 27.68 (-0.03)

Sally Beauty Holdings, Inc. Announces Fiscal 2016 Second Quarter Results
BusinessWire - Thu May 05, 5:30AM CDT
--Consolidated gross margin 49.7%
SBH: 27.68 (-0.03)

5 Solid Retail Stocks Likely to Beat this Earnings Season
Zacks Equity Research - Zacks Investment Research - Tue May 03, 3:25PM CDT
A rational investment can fetch higher returns on the heels of an earnings beat.
TJX: 77.34 (-0.34), RRGB: 49.74 (-1.03), SBH: 27.68 (-0.03), ULTA: 249.64 (+3.18), WEN: 10.20 (unch)

Cabela's (CAB) Q1 Earnings Top, Revenues Lag; View Intact
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 10:00AM CDT
Cabela's Incorporated (CAB) reported mixed first-quarter 2016 numbers with earnings surpassing the Zacks Consensus Estimate, while revenues missing the same.
HZO: 19.61 (-0.37), CAB: 49.47 (+0.35), SBH: 27.68 (-0.03), ULTA: 249.64 (+3.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...